| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.34 | 2e-10 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.3 | 6e-09 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.35 | 2e-08 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.3 | 5e-07 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.26 | 4e-06 |